Evidence map›Paper›PMID 37704738›Full record

ArticleScientific reports2023

Prebiotic inulin enhances gut microbial metabolism and anti-inflammation in apolipoprotein E4 mice with sex-specific implications.

Ya-Hsuan Chang, Lucille M Yanckello, George E Chlipala, Stefan J Green, Chetan Aware, Amelia Runge, Xin Xing, Anna Chen, Kathryn Wenger, Abeoseh Flemister and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Inulin may inhibit ADAM17 to delay atherosclerosis.Open medicine (Warsaw, Poland) · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. mTOR inhibition enhances synaptic and mitochondrial function in Alzheimer's disease in an APOE genotype-dependent manner.Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism · 2024
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Ya-Hsuan ChangDepartment of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, KY, 40536, USA.
Lucille M YanckelloDepartment of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, KY, 40536, USA.
George E ChlipalaResearch Informatics Core, University of Illinois Chicago, Chicago, IL, 60612, USA.
Stefan J GreenGenomics and Microbiome Core Facility, Rush University, Chicago, IL, 60612, USA.
Chetan AwareDepartment of Radiology, University of Missouri, Columbia, MO, 65212, USA.
Amelia RungeDepartment of Biological Sciences, University of Missouri, Columbia, MO, 65211, USA.
Xin XingDepartment of Radiology, University of Missouri, Columbia, MO, 65212, USA.
Anna ChenSanders Brown Center on Aging, University of Kentucky, Lexington, KY, 40536, USA.
Kathryn WengerDepartment of Biochemistry, University of Missouri, Columbia, MO, 65211, USA.
Abeoseh FlemisterDepartment of Radiology, University of Missouri, Columbia, MO, 65212, USA.
Caixia WanDepartment of Biological and Biomedical Engineering, University of Missouri, Columbia, MO, 65211, USA.
Ai-Ling LinDepartment of Pharmacology and Nutritional Sciences, University of Kentucky, Lexington, KY, 40536, USA. ai-ling.lin@health.missouri.edu.
University of Missouri · USUniversity of Kentucky · USRush University · USUniversity of Illinois Chicago · US

Funding

Strengthening Stakeholder Engagement in Human Research Protections.UL1TR002003 · NCATS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI KARNIK, NIRANJAN SUBHASH, MERMELSTEIN, ROBIN J. · 2016 to 2024
$33.7M
University of Kentucky Alzheimer's Disease Research CenterP30AG072946 · NIA · UNIVERSITY OF KENTUCKY · PI LINDA J VAN ELDIK · 2021 to 2026
$23.5M
Supplement to Prebiotics Intervention to Reduce Alzheimer's Disease Risk via Brain-Gut Axis in an APOE4 Mouse ModelRF1AG062480 · NIA · UNIVERSITY OF MISSOURI-COLUMBIA · PI LIN, AI-LING · 2019 to 2020
$3.6M
NCATS NIH HHS UL1 TR002003NIA NIH HHS P30 AG072946NIA NIH HHS RF1 AG062480
6 · The paper itself

Abstract

Gut dysbiosis has been identified as a crucial factor of Alzheimer's disease (AD) development for apolipoprotein E4 (APOE4) carriers. Inulin has shown the potential to mitigate dysbiosis. However, it remains unclear whether the dietary response varies depending on sex. In the study, we fed 4-month-old APOE4 mice with inulin for 16 weeks and performed shotgun metagenomic sequencing to determine changes in microbiome diversity, taxonomy, and functional gene pathways. We also formed the same experiments with APOE3 mice to identify whether there are APOE-genotype dependent responses to inulin. We found that APOE4 female mice fed with inulin had restored alpha diversity, significantly reduced Escherichia coli and inflammation-associated pathway responses. However, compared with APOE4 male mice, they had less metabolic responses, including the levels of short-chain fatty acids-producing bacteria and the associated kinases, especially those related to acetate and Erysipelotrichaceae. These diet- and sex- effects were less pronounced in the APOE3 mice, indicating that different APOE variants also play a significant role. The findings provide insights into the higher susceptibility of APOE4 females to AD, potentially due to inefficient energy production, and imply the importance of considering precision nutrition for mitigating dysbiosis and AD risk in the future.

Indexed as

Alzheimer DiseaseGastrointestinal MicrobiomeAnimalsAnti-Inflammatory AgentsApolipoprotein E3Apolipoprotein E4DysbiosisEscherichia coliFemaleInulinMaleMiceAnti-Inflammatory AgentsApolipoprotein E3Apolipoprotein E4Inulin

Identifiers

PMID37704738
PMCPMC10499887
OpenAlexW4386712964

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.